Penn's Abramson Cancer Center, an NCI-designated comprehensive cancer center, oversees one of the largest clinical trial programs in the country, with more than 200 trials available at any one time.
- Acute Lymphocytic Leukemia
- Acute Myelogenous Leukemia
- Bladder Cancer
- Brain Tumor
- Breast Cancer
- Cervical Cancer
- Chronic Lymphocytic Leukemia
- Chronic Myelogenous Leukemia
- Colorectal Cancer
- Endometrial/Uterine Cancer
- Esophageal Cancer
- Gastrointestinal Stromal Tumor (GIST)
- Head and Neck Cancer
- Hodgkin lymphoma
- Kidney Cancer
- Liver Cancer
